Mammalian odorant receptors (ORs) are crucial for establishing the functional organization of the olfactory system, but the mechanisms controlling their expression remain largely unexplained. Here, we utilized a transgenic approach to explore OR gene regulation. We determined that although olfactory sensory neurons (OSNs) are capable of supporting expression of multiple functional ORs, several levels of control ensure that each neuron normally expresses only a single odorant receptor. Surprisingly, this regulation extends beyond endogenous ORs even preventing expression of transgenes consisting of OR-coding sequences driven by synthetic promoters. Thus, part of the intrinsic feedback system must rely on elements present in the OR-coding sequence. Notably, by expressing the same transgenic ORs precociously in immature neurons, we have overcome this suppression and established a generic method to express any OR in $90% of OSNs. These results provide important insights into the hierarchy of OR gene expression and the vital role of the OR-coding sequence in this regulation.
INTRODUCTION
The mammalian sense of smell relies on the detection of odorants by a very large family of G protein coupled receptors (GPCRs), which, in mice, are encoded by approximately 1300 different genes (Buck and Axel, 1991; Zhang et al., 2007) . These odorant receptors (ORs) are expressed by olfactory sensory neurons (OSNs) residing deep within the nasal cavities in the main olfactory epithelium (MOE). A key feature of the mammalian olfactory system is that each OSN expresses just one of the 2600 potential OR alleles (Chess et al., 1994; Malnic et al., 1999) . This establishes the odorant selectivity of the neuron and marks its identity with that of a single specific OR protein. ORs also play an instructive role in the central projection of OSNs (Ressler et al., 1994; Vassar et al., 1994; Mombaerts et al., 1996; Wang et al., 1998) and the generation of a topographic map of odorant response properties in the olfactory bulb (Malnic et al., 1999; Belluscio and Katz, 2001) . Thus, precise control of OR gene expression is fundamental for the assembly and operation of the mammalian olfactory system.
How does an OSN select a single OR allele from this large gene family for expression? Over the past few years two important principles have emerged. First, short DNA sequences upstream of the OR transcriptional start site have been demonstrated to have the capacity to drive the expression of ORs and reporter genes in OSNs in patterns that resemble those of endogenous ORs (Qasba and Reed, 1998; Vassalli et al., 2002) . Second, OR gene expression prevents activation of other endogenous OR genes by utilizing an OR protein-dependent feedback mechanism (Serizawa et al., 2003; Lewcock and Reed, 2004; Shykind et al., 2004) . Recently, it was proposed that a putative transactivating element (H) may be involved in initiating expression of a single OR (Lomvardas et al., 2006) . In this model, the unique complex containing the H element would also serve as a target for feedback mechanisms that recognize the expression of a functional OR protein, thus preventing activation of additional OR alleles (Serizawa et al., 2003; Lewcock and Reed, 2004; Shykind et al., 2004) . However, more recent evidence demonstrates that the H region is not essential for expression of most ORs but rather functions in cis, much like the locus control region (LCR) of the globin gene cluster, controlling the expression of a local group of OR genes (Serizawa et al., 2000 (Serizawa et al., , 2003 Fuss et al., 2007) . Consequently, it was proposed that there may be many such LCR-like elements in the genome (Serizawa et al., 2004; Fuss et al., 2007) . While these studies provide useful information to help explain how a single OR might be chosen, many aspects of OR gene regulation still remain unclear. Here, we have used a new approach to broadly express single ORs in many OSNs and have uncovered the presence of several layers of regulation involved in OR gene suppression.
RESULTS

Receptor-Promoter Interactions Limit OR Expression
We have been interested in mechanisms governing OR gene expression and initially explored the use of broadly expressed OSN genes as a potential tactic to target expression of one olfactory receptor to many sensory neurons. Surprisingly, placing the OR-coding sequence of several different ORs under the control of two different promoters, olfactory marker protein (OMP) and Gg8, that efficiently drive expression of non-OR reporter genes in the olfactory system never resulted in transgenic OR expression in OSNs ( Figure 1A ). These two promoters were chosen because they are active at different developmental stages of the OSN life cycle. OMP is a marker for mature olfactory sensory neurons (Rogers et al., 1987) , whereas Gg8, a heterotrimeric G protein subunit, is expressed predominantly in immature OSNs, including some without dendritic or axonal projections (Ryba and Tirindelli, 1995) . Importantly, such immature neurons do not express detectable levels of ORs (Cheng and Reed, 2007) , and thus the observed suppression of Gg8-OR transgenes is independent of expression of endogenous ORs.
How does the inhibition of an OR transgene expression work, and could it also be part of the normal process controlling endogenous OR expression? We reasoned that perhaps the proximity of an OR-coding sequence to conserved elements of a general olfactory promoter (i.e., present in the OMP and Gg8 genes) (Wang and Reed, 1993 ) might provide a signal for transgene silencing. Therefore, we developed an alternative strategy whereby OR-coding sequences were placed downstream of a synthetic TetO promoter and crossed these transgenes into animals expressing tetracycline transactivators (TTA) to induce OR expression in the MOE (see Figure 1B) . To help track OR-transgene expression, we generated mice carrying bicistronic constructs consisting of TetO-OR-IRES-GFP or TetO-OR-IRES-lacZ using a number of different ORs (e.g., M72, M71, P2, P3, MOR28, and rat I7 and I9) .
In one set of studies, we made use of OMP-IRES-TTA knockin mice (OMP-TTA) (Yu et al., 2004) to express TTA in all mature olfactory neurons. We have now examined 37 different TetO-OR transgenic lines crossed into this background and, in 36 of these lines, observed broad but still limited expression of the transgenes in the MOE (Figures 2A-2D ). Transgene expression was restricted to only 10%-30% of OSNs (Figures 2A-2D ) with substantial variation in total number of transgene-expressing neurons between different individual mice of the same genotype. Thus, separating the olfactory promoter from the ORcoding sequence can partially overcome the suppression of OR transgene expression. However, the number and distribution of OSNs expressing the TetO-OR transgenes still did not approach the extent and uniformity that we observed for OMP-GFP (Potter et al., 2001 ) (see Figure 2E ). To explore this issue further, we examined the expression of TetO-OR transgenes in the vomeronasal organ (VNO), which also expresses OMP. Remarkably, the vast majority of the VNO sensory neurons express (A) Transgenic lines were generated using OMP and Gg8 promoters directly upstream of three different OR coding sequences. Surprisingly, none of these 31 lines expressed detectable transgenic mRNA in the MOE. (B) In an alternative approach, OR expression in OSNs was driven indirectly from olfactory promoters using a tetracycline-transactivatorbased system. We generated transgenic lines where the Gg8 promoter drives expression of TTA in immature OSNs (1) and used two knockin lines: one driving TTA under the control of the OMP promoter in most mature OSNs (2) and the other designed to express rTTA in a subset of mature OSNs that also express the P2 receptor (3). These tetracyclinetransactivator lines were crossed with multiple lines of TetO-OR mice (4) to express transgenic OR and bicistronically encoded GFP (or lacZ) in OSNs.
the TetO-OR transgenes ( Figure 2F ), closely mimicking the native expression of OMP. Thus, TetO-OR-transgenes are selectively silenced in the majority of OSNs.
Reciprocal Silencing of Transgenic and Endogenous Olfactory Receptors
Normally, an OSN only expresses a single olfactory receptor (Chess et al., 1994; Malnic et al., 1999) . Therefore, we wondered whether endogenous OR genes could be expressed in those cells where the OMP-driven OR transgene is on. To address this issue, we used double-labeling techniques to determine whether endogenous and transgenic ORs are coexpressed. We followed transgene expression using GFP fluorescence and carried out immunohistochemistry to examine expression of MOR28, an OR that is expressed in a particularly large subset of OSNs ($10% of OSNs in the ventral MOE) (Tsuboi et al., 1999; Serizawa et al., 2000; Barnea et al., 2004) . Figure 2G demonstrates that transgenic OR-positive neurons never coexpress the endogenous receptor MOR28, and conversely OSNs that express MOR28 do not express the transgene. Thus, expression of transgenic ORs driven by TTA indirectly from the OMP promoter is sufficient to prevent endogenous OR gene expression. Perhaps more remarkably, these data also imply that expression of endogenous ORs can prevent expression of TTA-driven OR transgenes. Since the TetO-OR transgenes consist of just the OR coding sequence linked to a synthetic expression cassette, such two-way suppression would require that the highly variable OR-coding sequences (Buck and Axel, 1991; Zhang et al., 2007) contain elements that are sufficient on the one hand to be silenced, and on the other, to silence endogenous OR expression.
If endogenous receptor expression provides the signals necessary to silence expression of the OMP-driven OR transgene, how does the transgene ever escape such suppression? We reasoned that stochastic differences in the timing of endogenous OR and OMP gene expression might allow transgenic OR expression to precede accumulation of endogenous receptor protein in a subset of OSNs. Thus, we hypothesized that precocious expression of TTA early in OSN development should increase the number of transgene-expressing cells, while delayed expression should further restrict the population of cells containing transgenic OR.
To test this hypothesis, we crossed our TetO-OR transgenes into backgrounds expressing TTA under the control of promoters that target TTA expression to populations of olfactory neurons at different developmental stages. To restrict TTA expression to OSNs already expressing an endogenous OR, we made use of mice expressing a bicistronic P2-IRES-rTTA allele (P2-rTTA) (Gogos et al., 2000) . In these animals, the rTTA is encoded by the same transcript as the endogenously expressed olfactory receptor P2, thus ensuring their coexpression. Mice carrying the P2-rTTA knockin and TetO-OR transgenes were weaned at 3 weeks of age, and rTTA activity was induced by feeding animals a high-concentration doxycycline diet for an additional 3 weeks. In situ hybridization confirmed expression of rTTA in a P2-like pattern ( Figure 3A ). However, these same animals had only an extremely small number of transgenic OR-positive cells. Counts from 4 different mice totaled just 7, 10, 12, and 64 reporter-positive cells in the whole MOE, corresponding with expression of the TetO-OR-IRES-GFP transgenes in less than 2% of the P2-IRES-rTTA-positive OSNs. Interestingly, the few cells expressing the OR transgene were all found at the base of the olfactory epithelium, right at the site where immature OSNs are located ( Figure 3B ). Together, these data demonstrate that the TetO-OR transgenes are silenced in the vast majority of cells expressing endogenous receptor but suggest that there is a period early in the development of the OSN where both endogenous (i.e., P2-IRES-rTTA) and transgenic receptor (TetO-OR-IRES-GFP) mRNA can be coexpressed. Presumably, this reflects the time required to accumulate sufficient receptor-protein expression to enable the presence of one OR to silence other OR genes. To explore whether there is a permissive time window for transgenic OR expression that precedes endogenous OR expression, we carried out the complementary experiment, whereby TetO-OR transgenes are now expressed in immature OSNs. We achieved this by generating transgenic mice where the Gg8 promoter drives expression of the tetracycline transactivator. Gg8 is robustly expressed in OSNs of young animals, but as animals age, Gg8 expression is limited to the regenerating olfactory neural population (Ryba and Tirindelli, 1995) . Three independent Gg8-TTA lines were generated, and two of these expressed TTA in at least 50% of the Gg8-positive OSNs (compare Figures 4A and 4B ). The Gg8-TTA mice were crossed with the various TetO-OR transgenic animals to determine whether the OR transgenes could be broadly expressed and not subjected to suppression as seen when driven by the late-expressing drivers. Indeed, Figure 4 demonstrates that the OR transgenes are now broadly expressed. Therefore, it appears that precocious OR transgene expression does overcome the endogenous OR-dependent suppression observed in OMP-TTA and P2-rTTA animals.
Are the Gg8-driven ORs functional and capable of suppressing endogenous receptor expression? To test for function we relied on expression of two receptors, rI7 and M72, whose activating ligands (octanal and acetophenone, respectively) have been identified (Zhao et al., 1998; Bozza et al., 2002) . Figure 4E shows that transgenic rI7-expressing neurons respond to octanal but not acetophenone, while M72-positive OSNs respond to acetophenone but not octanal. To examine the suppressing potential of these transgenic ORs, we investigated whether endogenous MOR28 or P2 (using a P2-IRES-tau-lacZ reporter animal) (Mombaerts et al., 1996) are ever coexpressed with Gg8-TTA-driven OR transgenes. Figure 4G demonstrates that transgenic OR-positive cells never coexpress endogenous MOR28. In addition, we have examined several thousand-P2-positive cells (Figure 4F ) from more than 30 mice and have never observed even a single P2-positive OSN that coexpresses the transgene.
Generation of Mice Expressing a Single OR in the Majority of OSNs
We have shown that by separating the olfactory promoter from the OR-coding sequence and expressing the OR precociously using the Gg8 promoter, we could overcome suppression of OR transgenes in OSNs. However, because Gg8 is predominantly active in developing rather than mature OSNs, the expression of transgenic ORs indirectly under its control is transient, and by 6 weeks of age, OR transgene expression is limited to the small population of regenerating neurons ( Figure 5A ). We reasoned that if indeed the first OR that is expressed establishes the cell identity and inhibits expression of other ORs, then mice carrying both Gg8-TTA and OMP-TTA should ensure activation and continued expression of the transgenic OR throughout the life of an OSN. This approach should result in transgene expression in a much larger population of mature OSNs than we observed with the OMP-TTA driver alone ( Figure 5B) and, in principle, should also completely prevent endogenous OR expression. Indeed, 6-week-old mice carrying both OMP-TTA and Gg8-TTA now express TTA-driven transgenic ORs in almost all OSNs ( Figures 5C  and 5D ). Moreover, as predicted, OSNs expressing the transgenic receptor do not coexpress endogenous ORs (MOR28 and P2), which are now restricted to an extremely small population of OSNs ( Figure 5E and data not shown). Together, these results provide a strong validation of our proposal that the first OR to be expressed silences other ORs. In addition, we have shown that by initiating OR expression in immature OSNs and maintaining it in mature neurons, it is now possible to drive expression of any TetO-OR transgene in essentially all OSNs.
Olfactory Receptor Sequence but Not Function Is Required for OR Silencing Next, we sought to determine whether nonodorant receptor GPCR transgenes are also subject to OR-dependent feedback inhibition in OSNs or if this is a property of functional ORs. First, we crossed OMP-TTA mice with either TetO-hT2R16 (a human taste receptor GPCR) (Mueller et al., 2005) or TetO-RASSL (a modified opioid receptor) (Redfern et al., 2000) and observed that these GPCRs are expressed in the vast majority of OMP-expressing OSNs (data not shown) demonstrating that the OSN suppression of ORs is not extended to GPCRs in general but is highly selective for ORs. Is a functional OR required to suppress the expression of other OR transcripts? To investigate this, we generated odorant receptors containing a mutation at the highly conserved DRY sequence, a motif located at the cytoplasmic face of helix 3 and essential for activating G proteins and downstream signaling pathways (Acharya and Karnik, 1996) . Notably, our data showed that the expression of a mutated TetO-M72 ALE transgene, where DRY has been changed to ALE (Figure 6B ), is indistinguishable from that of the fully functional TetO-OR allele (Figures 2 and 4) . Indeed, expression of the M72 ALE transgene both suppresses and is suppressible by endogenous ORs ( Figure 6B) . Independent experiments by Imai et al. (2006) using a different mutation of the DRY sequence are consistent with our data and also indicate that mutated ORs suppress activation of other endogenous OR genes.
Expression of Multiple Functional Olfactory Receptors in an OSN
The expression of a single OR in a mammalian OSN involves a number of layers of regulation (e.g., selection, promoter-dependent inhibition and OR-dependent silencing) that combine to prevent multiple different OR genes from being coexpressed. Can such a complex system be overridden to allow expression of multiple functional ORs within a single OSN? To address this issue we sought to express M72 and rI7 (two receptors that are known to respond to different odorants; see Figure 4E ) in a single neuron. Thus, we could use electrophysiological recordings to unequivocally determine whether a given OSN did indeed express two functional ORs. Our approach involved generating mice carrying a single construct expressing these two ORs from the same regulatory sequence, TetO-M72-IRES-rI7-IRES-GFP (TetO-M72-rI7; see Figure 6C ). When TetO-M72-rI7 was crossed to OMP-TTA (or Gg8-TTA), the transgene was expressed in a subset of OSNs (just like other TetO-OR transgenes) that now contained mRNA for both transgenic receptors (e.g., see Figure 6D ). More importantly, single-cell recordings demonstrated that GFP-labeled neurons responded robustly both to octanal and acetophenone ( Figure 6E ). Thus, while mammalian OSNs are tightly regulated to transcribe only a single OR allele, they are quite capable of translating, processing, and utilizing two different odorant receptors. Similarly, there was no overlap between transgenic (green, GFP) and the endogenous OR, MOR28 (red; immunofluorescence) in Gg8-TTA, TetO-M72 double-transgenic animals (G). Note that the different levels of GFP-fluorescence reflect regional differences in Gg8-TTA expression, with higher expression in dorsal regions (F; left panel) compared to ventral regions where MOR28 is predominantly expressed (G). Scale bar, 20 mm.
DISCUSSION
A mammalian olfactory neuron expresses a single olfactory receptor, yet it has over 2500 potential OR alleles to choose from. How this process is orchestrated is a central question in cellular and molecular neurobiology. Recent studies in mice have uncovered two important features of OR gene control. First, a conserved DNA sequence upstream of the MOR28 gene, the H element, has been shown to work in cis to activate any one (but only one at a time) of a handful of downstream OR genes (Serizawa et al., 2000 (Serizawa et al., , 2003 Fuss et al., 2007) . Remarkably, in the nucleus of an OSN, this same element associates in a chromosomal complex with the actively expressed OR allele, even if the OR is from a different genomic location. These results led Lomvardas and coworkers to propose that the H elements may also act in trans to select the expression of a single OR per neuron (Lomvardas et al., 2006) . Second, several studies examined the expression of OR pseudogenes with various mutations that all prevented translation of a full length odorant receptor (Serizawa et al., 2003; Lewcock and Reed, 2004; Feinstein et al., 2004) . Notably, this type of OR pseudogene was often coexpressed with a functional OR gene in an OSN. Complementary experiments that directly examined the stability of receptor choice demonstrated that OR switching normally occurs, albeit at a low frequency in immature OSNs, but is dramatically enhanced whenever an OSN selects a nontranslatable OR mutant (Shykind et al., 2004) . Thus, it was suggested (Serizawa et al., 2003; Lewcock and Reed, 2004; Shykind et al., 2004 ) that the odorant receptor protein is required to initiate a regulatory feedback process that ensures each OSN expresses a single functional OR allele rather than an OR pseudogene (a significant problem for mice and humans, where approximately 20% and 70% of OR genes are nonfunctional) (Zhang et al., 2007) .
In this study, we sought to examine the regulatory hierarchy of OR gene expression by experimentally dissociating the process of gene selection from feedback inhibition. By using heterologous promoters to express transgenic ORs in the MOE, we demonstrated that although an OSN can be forced to functionally express two different ORs, multiple layers of control operate to ensure that normally just one OR is expressed in each olfactory neuron.
Together, our results revealed several layers of regulation in the hierarchy that controls odorant receptor choice. First, we showed that transgenic ORs driven from a synthetic TetO promoter are capable of suppressing selection and/or expression of endogenous OR genes. This finding is consistent with the OR-mediated feedback inhibition described previously (Serizawa et al., 2003; Lewcock and Reed, 2004; Shykind et al., 2004) . What signals are important for this type of suppression? While the mechanisms underlying this process have not been defined, it was recognized that OR and immunoglobulin gene regulation share features including monoallelic gene expression and feedback inhibition (Serizawa et al., 2003; Lewcock and Reed, 2004; Shykind et al., 2004) . In the immune system, developing B lymphocytes require a functional pre-B cell receptor that initiates a tyrosine kinase cascade, which transmits the signal to prevent further gene rearrangement and ensures monoallelic expression (Nemazee, 2000) . Therefore, it was anticipated that signaling through an odorant receptor might play an important role in maintaining the monoallelic expression of a functional OR in each OSN (Serizawa et al., 2003; Lewcock and Reed, 2004; Shykind et al., 2004) . Interestingly, our data demonstrate that suppression of endogenous receptors still occurs even with an OR transgene, TetO-M72 ALE , that contains mutations making it incapable of activating a G protein pathway (see also Imai et al., 2006) . In combination, these findings imply that although an OSN needs to be able to detect expression of a full-length OR protein, signaling through the olfactory signal transduction pathway is not necessary for the feedback inhibition.
Second, we demonstrated that while it has not been experimentally feasible to drive OR expression using general olfactory promoters in engineered mice, this suppression can be overcome by separating the promoter from the OR coding sequence; this is most dramatically illustrated when comparing Gg8 directly driving an OR transgene versus Gg8 driving TTA, which in turn drives expression of a TetO-OR transgene. Third, and perhaps most surprisingly, expression of an endogenous OR prevents expression of transgenic ORs, even if driven by completely unrelated regulatory sequences like those of the bacterial tetracycline system. Indeed, although TTA is found in the vast majority of the OSNs in OMP-TTA knockin mice, TetO-driven ORs are only expressed in a fraction of these cells. This means that the short ($1 kb) and highly variable OR coding sequences themselves (Buck and Axel, 1991; Zhang et al., 2007) are sufficient to mark a transgene as an OR locus and make them one target for feedback inhibition. However, our data do not rule out the existence of other targets, e.g., at the level of gene selection as recently postulated (Lomvardas et al., 2006; Serizawa et al., 2006) . Finally, we showed that precocious expression of a transgenic OR ensures suppression of endogenous receptors, thus suggesting a ''first-takes-all/early-bird-gets-theworm'' paradigm.
Mammalian odorant receptors are recognized to have at least three quite different functions in OSNs: (1) Figure 6 . GPCR Function Is Not Required for OR Suppression, and OSNs Are Competent to Express Two Functional Receptors (A-E) Diagram indicates that mutation of the highly conserved DRY sequence of M72 to ALE (red residues) prevents G protein coupling (Acharya and Karnik, 1996) . However, this mutation has no influence on the mutually exclusive expression of the transgenic (TetO-M72 ALE ) and endogenous receptors driven by OMP-TTA (B; left panel) or Gg8-TTA (B; right panel). Shown are TetO-M72 ALE expression (green) with endogenous MOR28 immunofluorescence (B; left panel, red) and b-galactosidase immunostaining in 3-week-old mice also carrying a P2-lacZ allele (B; right panel, red). The transgene used to coexpress two odorant receptors in an OSN is schematically shown (C). In situ hybridization and GFP fluorescence (D) indicate that both ORs (M72 and rI7) and GFP are expressed in the MOE of 3-week-old mice when driven by OMP-TTA. Moreover, functional recordings (E) from GFP-labeled OSNs (1-to 2-week-old animals) demonstrate that these neurons coexpress M72 and rI7 and respond to both octanal (OCT) and acetophenone (ACE); insets show that both odorants trigger action potentials (n = 17 cells). Scale bar, 10 mm (B), 20 mm (D).
determining the odorant selectivity (sensory tuning) of the neurons (Zhao et al., 1998) , (2) playing an instructive role in targeting their axonal connections in the olfactory bulb (Ressler et al., 1994; Vassar et al., 1994; Mombaerts et al., 1996; Wang et al., 1998) , and (3) functioning as the trigger for feedback inhibition (Serizawa et al., 2003; Lewcock and Reed, 2004; Shykind et al., 2004) . Our results have provided fascinating new insight into the control of OR gene expression and raise a number of challenging questions; for example, how does an OSN determine whether it is expressing an OR gene? What is the nature of the feedback mechanism that ensures continued expression of this one OR while keeping all other OR genes silent even when driven by a synthetic promoter? And what features of an OR coding sequence does an OSN recognize to implement this complex regulation? The approach described here that reliably allows expression of any receptor throughout the entire epithelium should help address some of these issues and thereby aid dissection of the mechanisms regulating the expression of OR genes.
EXPERIMENTAL PROCEDURES Mice
All transgenic lines were produced by pronuclear injection of zygotes from FVB/N mice. The Gg8-TTA construct consisted of À2561 to +3 (the location of the Gg8 ATG) fused to TTA (Tet-off). TetO-ORs (TetO-OR-IRES-reporter) utilized full-length OR receptor sequences in a standard TetO expression vector (Gogos et al., 2000) . Three lines of Gg8-TTA transgenic mice were obtained, all with variation in TTAmRNA expression. We selected the line with the highest number of TTA-positive OSNs where approximately 60%-80% of Gg8-expressing cells (variation reflecting mouse-to-mouse differences) are positive for TTA. Direct Gg8-OR constructs utilized the same Gg8-upstream sequence; OMP-OR constructs used a previously described promoter region (Walters et al., 1996) . More than 80 independent TetO-OR-IRES-reporter lines were generated containing ten different OR genes and either a GFP or lacZ reporter. PCR-mediated mutagenesis was used to introduce the DRY-to-ALE mutation in both the M72 and rI7 receptors to generate TetO-M72 ALE and TetO-rI7 ALE transgenes (both of which produced equivalent results when expressed in OSNs). For doxycycline treatment to induce rTTA (Tet-on) activation, mice were weaned at 3 weeks and were then fed a diet (Bioserv) containing 6 g/kg doxycycline for 3 weeks, at which point olfactory epithelia were harvested for analysis. Knockin mice: OMP-TTA, P2-rTTA (P2-IRESrTTA), OMP-GFP (OMP-IRES-GFP), and P2-lacZ (P2-IRES-Tau-lacZ) mice have been described previously (Mombaerts et al., 1996; Gogos et al., 2000; Potter et al., 2001; Bozza et al., 2002) and were generous gifts from Joseph Gogos and Peter Mombaerts. For all experiments, the transgenes were hemizygous and knockin backgrounds heterozygous.
Histology and Fluorescence Imaging
In situ hybridization and immunhistochemistry were carried out as described previously (Belluscio et al., 2002; Zhao et al., 2003) . Antibodies against b-galactosidase and OMP were from MP Biochemicals and Wako Chemicals USA, Inc. and were used at 1:500 and 1:5000 dilutions, respectively. Anti-MOR28 antibody was generously provided by Richard Axel and was used at a 1:6000 dilution . Cy3-labaeled secondary antibodies (used at 1:500 dilutions) were from Jackson ImmunoResearch. Confocal images (1 mm optical sections) were collected using a Zeiss LSM-510-Meta confocal (Carl Zeiss, Inc.). Fluorophores used were GFP (excitation 488, emission 507) and Cy3 (excitation 550, emission 570).
Functional Recordings
Electrophysiological recordings on olfactory sensory neurons were carried out as described previously (Ma et al., 1999) . Briefly, GFP-positive cells of $2-week-old animals were identified by fluorescence and DIC optics (Olympus BX51WI), and recordings were targeted to dendritic knobs using perforated-patch configuration. Amphotericin B was included in the patch pipette solution at a final concentration of 240 mg/ml.
